194 related articles for article (PubMed ID: 21046180)
1. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.
McCarthy JJ; Linnertz C; Saucier L; Burke JR; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
Neurogenetics; 2011 Feb; 12(1):59-64. PubMed ID: 21046180
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.
Linnertz C; Saucier L; Ge D; Cronin KD; Burke JR; Browndyke JN; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
PLoS One; 2009 Oct; 4(10):e7480. PubMed ID: 19834617
[TBL] [Abstract][Full Text] [Related]
3. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
[TBL] [Abstract][Full Text] [Related]
4. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
[TBL] [Abstract][Full Text] [Related]
5. SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.
Blažeković A; Jerčić KG; Borovečki F
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944443
[TBL] [Abstract][Full Text] [Related]
6. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
[TBL] [Abstract][Full Text] [Related]
8. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
9. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability in SNCA and Parkinson's disease.
Pihlstrøm L; Toft M
Neurogenetics; 2011 Nov; 12(4):283-93. PubMed ID: 21800132
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
12. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
[TBL] [Abstract][Full Text] [Related]
13. A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.
Sotiriou S; Gibney G; Baxevanis AD; Nussbaum RL
Neurosci Lett; 2009 Sep; 461(2):196-201. PubMed ID: 19540308
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
Pihlstrøm L; Blauwendraat C; Cappelletti C; Berge-Seidl V; Langmyhr M; Henriksen SP; van de Berg WDJ; Gibbs JR; Cookson MR; ; ; Singleton AB; Nalls MA; Toft M
Ann Neurol; 2018 Jul; 84(1):117-129. PubMed ID: 30146727
[TBL] [Abstract][Full Text] [Related]
15. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
[TBL] [Abstract][Full Text] [Related]
17. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
[TBL] [Abstract][Full Text] [Related]
18. Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.
Schmitt I; Wüllner U; van Rooyen JP; Khazneh H; Becker J; Volk A; Kubisch C; Becker T; Kostic VS; Klein C; Ramirez A
Eur J Hum Genet; 2012 Dec; 20(12):1265-9. PubMed ID: 22617348
[TBL] [Abstract][Full Text] [Related]
19. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
[TBL] [Abstract][Full Text] [Related]
20. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]